Abstract 580P
Background
Breast Ca (BC) & Cervical Ca (CC) are common yet preventable & treatable forms of Ca in Philippines, hence, need to prioritize & strengthen community-organized programs to screen/ early detect & treat, improving survival outcomes. The Philippine Cancer Society (PCS) -Quezon City (QC) ACT NOW PLUS program aims to detect BC & CC thru screening/ stage shifting using online pt self-education/ evaluation, integrated mobile clinics (self/ CBE,breast UTZ, VIA, self-collection HPV test) & navigated to Centers w/ Medical Access Programs.
Methods
QC women were advised to register at actnow.philcancer.org.ph to access videos on breast health, cancer & self-exam. Pt self-reported S/sx & risk factors were triaged into high- & low risk. CC screening by VIA or self-collection HPV test were done. Immediate scheduling of high-risk group to mobile clinic visit was done while low-risk group were advised to visit yearly. Pteducation, CBE & Cervical Exam & UTZ were performed. Both high- & low-risk groups were scheduled for teleconsult or clinic visits. Suspicious breast & cervical findings were referred for biopsy. Confirmed Ca were referred to centers w/ treatment access programs.
Results
From June '23 – May '24, 28370 women screened, 804 were clinically high-risk for BC, 229 had breast lumps & only 23 had breast UTZ BIRADS 4- 5. 7 had negative biopsy. 16 confirmed positive eBC referred for treatment. Turnaround time from work-up to treatment was 4 weeks. 120 had positive VIA result but negative on confirmatory tests. 85% had fair comprehension of educational videos.
Conclusions
ACT Now PLUS is an expanded program of PCS, initated w/ QC to enhance community education & early detection of BC & CC, provide immediate navigation & access to treatment, to improve outcomes. In a limited resource setting, strengthening community-based Ca screening & navigation to available financial & medical access programs, to improve treatment compliance, hence, survival, can be done via the ACT NOW Plus program. Other local health units are encouraged to ACT NOW.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Philippine Cancer Society, Inc.
Funding
Philippine Cancer Society Inc.
Disclosure
All authors have declared no conflicts of interest.